Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 157

1.

Joint associations of β-amyloidosis and cortical thickness with cognition.

Knopman DS, Lundt ES, Therneau TM, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, Petersen RC, Jack CR Jr..

Neurobiol Aging. 2018 Feb 2;65:121-131. doi: 10.1016/j.neurobiolaging.2018.01.017. [Epub ahead of print]

PMID:
29471214
2.

In vivo 18F-AV-1451 tau-PET signal in MAPT mutation carriers varies by expected tau isoforms.

Jones DT, Knopman DS, Graff-Radford J, Syrjanen JA, Senjem ML, Schwarz CG, Dheel C, Wszolek Z, Rademakers R, Kantarci K, Petersen RC, Jack CR Jr, Lowe VJ, Boeve BF.

Neurology. 2018 Feb 9. pii: 10.1212/WNL.0000000000005117. doi: 10.1212/WNL.0000000000005117. [Epub ahead of print]

PMID:
29440563
3.

Cervical spinal cord atrophy: An early marker of progressive MS onset.

Zeydan B, Gu X, Atkinson EJ, Keegan BM, Weinshenker BG, Tillema JM, Pelletier D, Azevedo CJ, Lebrun-Frenay C, Siva A, Okuda DT, Kantarci K, Kantarci OH.

Neurol Neuroimmunol Neuroinflamm. 2018 Jan 22;5(2):e435. doi: 10.1212/NXI.0000000000000435. eCollection 2018 Mar.

4.

Frequency of Acute and Subacute Infarcts in a Population-Based Study.

Arnold Fiebelkorn C, Vemuri P, Rabinstein AA, Mielke MM, Przybelski SA, Kantarci K, Jones DT, Brown RD Jr., Knopman DS, Petersen RC, Jack CR Jr., Graff-Radford J.

Mayo Clin Proc. 2018 Feb 6. pii: S0025-6196(17)30872-8. doi: 10.1016/j.mayocp.2017.11.021. [Epub ahead of print]

PMID:
29426582
5.

Hormone therapy and urine protein excretion: a multiracial cohort study, systematic review, and meta-analysis.

Kattah AG, Suarez MLG, Milic N, Kantarci K, Zeydan B, Mosley T, Turner ST, Ware EB, Kardia SLR, Garovic VD.

Menopause. 2018 Jan 29. doi: 10.1097/GME.0000000000001062. [Epub ahead of print]

PMID:
29381664
6.

Sex differences in cerebrovascular pathologies on FLAIR in cognitively unimpaired elderly.

Fatemi F, Kantarci K, Graff-Radford J, Preboske GM, Weigand SD, Przybelski SA, Knopman DS, Machulda MM, Roberts RO, Mielke MM, Petersen RC, Jack CR Jr, Vemuri P.

Neurology. 2018 Feb 6;90(6):e466-e473. doi: 10.1212/WNL.0000000000004913. Epub 2018 Jan 17.

PMID:
29343465
7.

Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia.

Lowe VJ, Wiste HJ, Senjem ML, Weigand SD, Therneau TM, Boeve BF, Josephs KA, Fang P, Pandey MK, Murray ME, Kantarci K, Jones DT, Vemuri P, Graff-Radford J, Schwarz CG, Machulda MM, Mielke MM, Roberts RO, Knopman DS, Petersen RC, Jack CR Jr.

Brain. 2018 Jan 1;141(1):271-287. doi: 10.1093/brain/awx320.

PMID:
29228201
8.

Association Between Microinfarcts and Blood Pressure Trajectories.

Graff-Radford J, Raman MR, Rabinstein AA, Przybelski SA, Lesnick TG, Boeve BF, Murray ME, Dickson DW, Reichard RR, Parisi JE, Knopman DS, Petersen RC, Jack CR Jr, Kantarci K.

JAMA Neurol. 2018 Feb 1;75(2):212-218. doi: 10.1001/jamaneurol.2017.3392.

PMID:
29204605
9.

Cohort profile: the Mayo Clinic Cohort Study of Oophorectomy and Aging-2 (MOA-2) in Olmsted County, Minnesota (USA).

Rocca WA, Gazzuola Rocca L, Smith CY, Grossardt BR, Faubion SS, Shuster LT, Stewart EA, Mielke MM, Kantarci K, Miller VM.

BMJ Open. 2017 Nov 20;7(11):e018861. doi: 10.1136/bmjopen-2017-018861.

10.

Tau, amyloid, and cascading network failure across the Alzheimer's disease spectrum.

Jones DT, Graff-Radford J, Lowe VJ, Wiste HJ, Gunter JL, Senjem ML, Botha H, Kantarci K, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr.

Cortex. 2017 Dec;97:143-159. doi: 10.1016/j.cortex.2017.09.018. Epub 2017 Oct 3.

11.

The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies.

Ferman TJ, Aoki N, Crook JE, Murray ME, Graff-Radford NR, van Gerpen JA, Uitti RJ, Wszolek ZK, Graff-Radford J, Pedraza O, Kantarci K, Boeve BF, Dickson DW.

Alzheimers Dement. 2017 Oct 31. pii: S1552-5260(17)33775-5. doi: 10.1016/j.jalz.2017.09.014. [Epub ahead of print]

PMID:
29100980
12.

Prevalence and Natural History of Superficial Siderosis: A Population-Based Study.

Pichler M, Vemuri P, Rabinstein AA, Aakre J, Flemming KD, Brown RD Jr, Kumar N, Kantarci K, Kremers W, Mielke MM, Knopman DS, Jack CR Jr, Petersen RC, Lowe V, Graff-Radford J.

Stroke. 2017 Dec;48(12):3210-3214. doi: 10.1161/STROKEAHA.117.018974. Epub 2017 Oct 25.

PMID:
29070715
13.

Multiple-dose ponezumab for mild-to-moderate Alzheimer's disease: Safety and efficacy.

Landen JW, Cohen S, Billing CB Jr, Cronenberger C, Styren S, Burstein AH, Sattler C, Lee JH, Jack CR Jr, Kantarci K, Schwartz PF, Duggan WT, Zhao Q, Sprenger K, Bednar MM, Binneman B.

Alzheimers Dement (N Y). 2017 May 10;3(3):339-347. doi: 10.1016/j.trci.2017.04.003. eCollection 2017 Sep.

14.

Neuroimaging Correlates of Cerebral Microbleeds: The ARIC Study (Atherosclerosis Risk in Communities).

Graff-Radford J, Simino J, Kantarci K, Mosley TH Jr, Griswold ME, Windham BG, Sharrett AR, Albert MS, Gottesman RF, Jack CR Jr, Vemuri P, Knopman DS.

Stroke. 2017 Nov;48(11):2964-2972. doi: 10.1161/STROKEAHA.117.018336. Epub 2017 Oct 10.

PMID:
29018129
15.

Uptake of AV-1451 in meningiomas.

Bruinsma TJ, Johnson DR, Fang P, Senjem M, Josephs KA, Whitwell JL, Boeve BF, Pandey MK, Kantarci K, Jones DT, Vemuri P, Murray M, Graff-Radford J, Schwarz CG, Knopman DS, Petersen RC, Jack CR Jr, Lowe VJ.

Ann Nucl Med. 2017 Dec;31(10):736-743. doi: 10.1007/s12149-017-1205-0. Epub 2017 Sep 8.

PMID:
28887599
16.

1H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adults.

Nedelska Z, Przybelski SA, Lesnick TG, Schwarz CG, Lowe VJ, Machulda MM, Kremers WK, Mielke MM, Roberts RO, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr, Kantarci K.

Neurology. 2017 Sep 26;89(13):1391-1399. doi: 10.1212/WNL.0000000000004421. Epub 2017 Aug 25.

17.

Influence of preeclampsia and late-life hypertension on MRI measures of cortical atrophy.

Raman MR, Tosakulwong N, Zuk SM, Senjem ML, White WM, Fields JA, Mielke MM, Lesnick TG, Bailey KR, Jack CR Jr, Miller VM, Garovic VD, Kantarci K.

J Hypertens. 2017 Dec;35(12):2479-2485. doi: 10.1097/HJH.0000000000001492.

18.

Myelopathy in Behçet's disease: The Bagel Sign.

Uygunoglu U, Zeydan B, Ozguler Y, Ugurlu S, Seyahi E, Kocer N, Islak C, Kantarci K, Saip S, Siva A, Kantarci OH.

Ann Neurol. 2017 Aug;82(2):288-298. doi: 10.1002/ana.25004. Epub 2017 Aug 10.

PMID:
28749553
19.

Decreased Glutamate Levels in Patients with Amnestic Mild Cognitive Impairment: An sLASER Proton MR Spectroscopy and PiB-PET Study.

Zeydan B, Deelchand DK, Tosakulwong N, Lesnick TG, Kantarci OH, Machulda MM, Knopman DS, Lowe VJ, Jack CR Jr, Petersen RC, Öz G, Kantarci K.

J Neuroimaging. 2017 Nov;27(6):630-636. doi: 10.1111/jon.12454. Epub 2017 Jun 29.

PMID:
28661060
20.

Improved localization, spectral quality, and repeatability with advanced MRS methodology in the clinical setting.

Deelchand DK, Kantarci K, Öz G.

Magn Reson Med. 2018 Mar;79(3):1241-1250. doi: 10.1002/mrm.26788. Epub 2017 Jun 15.

PMID:
28618085
21.

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O'Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K.

Neurology. 2017 Jul 4;89(1):88-100. doi: 10.1212/WNL.0000000000004058. Epub 2017 Jun 7. Review.

22.

White-matter integrity on DTI and the pathologic staging of Alzheimer's disease.

Kantarci K, Murray ME, Schwarz CG, Reid RI, Przybelski SA, Lesnick T, Zuk SM, Raman MR, Senjem ML, Gunter JL, Boeve BF, Knopman DS, Parisi JE, Petersen RC, Jack CR Jr., Dickson DW.

Neurobiol Aging. 2017 Aug;56:172-179. doi: 10.1016/j.neurobiolaging.2017.04.024. Epub 2017 May 4.

23.

Midlife and Late-Life Vascular Risk Factors and White Matter Microstructural Integrity: The Atherosclerosis Risk in Communities Neurocognitive Study.

Power MC, Tingle JV, Reid RI, Huang J, Sharrett AR, Coresh J, Griswold M, Kantarci K, Jack CR Jr, Knopman D, Gottesman RF, Mosley TH.

J Am Heart Assoc. 2017 May 18;6(5). pii: e005608. doi: 10.1161/JAHA.117.005608.

24.

Population-Based Prevalence of Cerebral Cavernous Malformations in Older Adults: Mayo Clinic Study of Aging.

Flemming KD, Graff-Radford J, Aakre J, Kantarci K, Lanzino G, Brown RD Jr, Mielke MM, Roberts RO, Kremers W, Knopman DS, Petersen RC, Jack CR Jr.

JAMA Neurol. 2017 Jul 1;74(7):801-805. doi: 10.1001/jamaneurol.2017.0439.

PMID:
28492932
25.

Pittsburgh compound-B PET white matter imaging and cognitive function in late multiple sclerosis.

Zeydan B, Lowe VJ, Schwarz CG, Przybelski SA, Tosakulwong N, Zuk SM, Senjem ML, Gunter JL, Roberts RO, Mielke MM, Benarroch EE, Rodriguez M, Machulda MM, Lesnick TG, Knopman DS, Petersen RC, Jack CR Jr, Kantarci K, Kantarci OH.

Mult Scler. 2017 May 1:1352458517707346. doi: 10.1177/1352458517707346. [Epub ahead of print]

PMID:
28474977
26.

Aortic hemodynamics and white matter hyperintensities in normotensive postmenopausal women.

Barnes JN, Harvey RE, Zuk SM, Lundt ES, Lesnick TG, Gunter JL, Senjem ML, Shuster LT, Miller VM, Jack CR Jr, Joyner MJ, Kantarci K.

J Neurol. 2017 May;264(5):938-945. doi: 10.1007/s00415-017-8476-1. Epub 2017 Apr 7.

27.

Preeclampsia and cognitive impairment later in life.

Fields JA, Garovic VD, Mielke MM, Kantarci K, Jayachandran M, White WM, Butts AM, Graff-Radford J, Lahr BD, Bailey KR, Miller VM.

Am J Obstet Gynecol. 2017 Jul;217(1):74.e1-74.e11. doi: 10.1016/j.ajog.2017.03.008. Epub 2017 Mar 18.

28.

Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART).

Josephs KA, Murray ME, Tosakulwong N, Whitwell JL, Knopman DS, Machulda MM, Weigand SD, Boeve BF, Kantarci K, Petrucelli L, Lowe VJ, Jack CR Jr, Petersen RC, Parisi JE, Dickson DW.

Acta Neuropathol. 2017 May;133(5):705-715. doi: 10.1007/s00401-017-1681-2. Epub 2017 Feb 3.

PMID:
28160067
29.

Duration and Pathologic Correlates of Lewy Body Disease.

Graff-Radford J, Aakre J, Savica R, Boeve B, Kremers WK, Ferman TJ, Jones DT, Kantarci K, Knopman DS, Dickson DW, Kukull WA, Petersen RC.

JAMA Neurol. 2017 Mar 1;74(3):310-315. doi: 10.1001/jamaneurol.2016.4926.

30.

Imaging markers of cerebrovascular pathologies: Pathophysiology, clinical presentation, and risk factors.

Raman MR, Kantarci K, Murray ME, Jack CR Jr, Vemuri P.

Alzheimers Dement (Amst). 2016 Dec 18;5:5-14. doi: 10.1016/j.dadm.2016.12.006. eCollection 2016. Review.

31.

A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity.

Schwarz CG, Gunter JL, Wiste HJ, Przybelski SA, Weigand SD, Ward CP, Senjem ML, Vemuri P, Murray ME, Dickson DW, Parisi JE, Kantarci K, Weiner MW, Petersen RC, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage Clin. 2016 May 30;11:802-812. doi: 10.1016/j.nicl.2016.05.017. eCollection 2016.

32.

AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies.

Kantarci K, Lowe VJ, Boeve BF, Senjem ML, Tosakulwong N, Lesnick TG, Spychalla AJ, Gunter JL, Fields JA, Graff-Radford J, Ferman TJ, Jones DT, Murray ME, Knopman DS, Jack CR Jr, Petersen RC.

Ann Neurol. 2017 Jan;81(1):58-67. doi: 10.1002/ana.24825. Epub 2016 Dec 19.

33.

Hippocampal volumes predict risk of dementia with Lewy bodies in mild cognitive impairment.

Kantarci K, Lesnick T, Ferman TJ, Przybelski SA, Boeve BF, Smith GE, Kremers WK, Knopman DS, Jack CR Jr, Petersen RC.

Neurology. 2016 Nov 29;87(22):2317-2323. Epub 2016 Nov 2.

34.

Defining imaging biomarker cut points for brain aging and Alzheimer's disease.

Jack CR Jr., Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, Gunter JL, Senjem ML, Jones DT, Kantarci K, Machulda MM, Mielke MM, Roberts RO, Vemuri P, Reyes DA, Petersen RC.

Alzheimers Dement. 2017 Mar;13(3):205-216. doi: 10.1016/j.jalz.2016.08.005. Epub 2016 Sep 30.

35.

Association of Kidney Function Biomarkers with Brain MRI Findings: The BRINK Study.

Vemuri P, Knopman DS, Jack CR, Lundt ES, Weigand SD, Zuk SM, Thostenson KB, Reid RI, Kantarci K, Slinin Y, Lakshminarayan K, Davey CS, Murray A.

J Alzheimers Dis. 2017;55(3):1069-1082.

36.

An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease.

Sarro L, Tosakulwong N, Schwarz CG, Graff-Radford J, Przybelski SA, Lesnick TG, Zuk SM, Reid RI, Raman MR, Boeve BF, Ferman TJ, Knopman DS, Comi G, Filippi M, Murray ME, Parisi JE, Dickson DW, Petersen RC, Jack CR Jr., Kantarci K.

Alzheimers Dement. 2017 Mar;13(3):257-266. doi: 10.1016/j.jalz.2016.07.003. Epub 2016 Aug 10.

37.

LRRK2 variation and dementia with Lewy bodies.

Heckman MG, Soto-Ortolaza AI, Contreras MYS, Murray ME, Pedraza O, Diehl NN, Walton R, Labbé C, Lorenzo-Betancor O, Uitti RJ, van Gerpen J, Ertekin-Taner N, Smith GE, Kantarci K, Savica R, Jones DT, Graff-Radford J, Knopman DS, Lowe VJ, Jack CR Jr, Petersen RC, Parisi JE, Rademakers R, Wszolek ZK, Graff-Radford NR, Ferman TJ, Dickson DW, Boeve BF, Ross OA.

Parkinsonism Relat Disord. 2016 Oct;31:98-103. doi: 10.1016/j.parkreldis.2016.07.015. Epub 2016 Jul 29.

38.

Arguing against the proposed definition changes of PD.

Boeve BF, Dickson DW, Duda JE, Ferman TJ, Galasko DR, Galvin JE, Goldman JG, Growdon JH, Hurtig HI, Kaufer DI, Kantarci K, Leverenz JB, Lippa CF, Lopez OL, McKeith IG, Singleton AB, Taylor A, Tsuang D, Weintraub D, Zabetian CP.

Mov Disord. 2016 Nov;31(11):1619-1622. doi: 10.1002/mds.26721. Epub 2016 Aug 5. Review.

39.

Effects of hormone therapy on brain structure: A randomized controlled trial.

Kantarci K, Tosakulwong N, Lesnick TG, Zuk SM, Gunter JL, Gleason CE, Wharton W, Dowling NM, Vemuri P, Senjem ML, Shuster LT, Bailey KR, Rocca WA, Jack CR Jr, Asthana S, Miller VM.

Neurology. 2016 Aug 30;87(9):887-96. doi: 10.1212/WNL.0000000000002970. Epub 2016 Jul 29.

40.

Evolution of neurodegeneration-imaging biomarkers from clinically normal to dementia in the Alzheimer disease spectrum.

Knopman DS, Jack CR Jr, Lundt ES, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, Petersen RC.

Neurobiol Aging. 2016 Oct;46:32-42. doi: 10.1016/j.neurobiolaging.2016.06.003. Epub 2016 Jun 16.

41.

RAB39B gene mutations are not a common cause of Parkinson's disease or dementia with Lewy bodies.

Hodges K, Brewer SS, Labbé C, Soto-Ortolaza AI, Walton RL, Strongosky AJ, Uitti RJ, van Gerpen JA, Ertekin-Taner N, Kantarci K, Lowe VJ, Parisi JE, Savica R, Graff-Radford J, Jones DT, Knopman DS, Petersen RC, Murray ME, Graff-Radford NR, Ferman TJ, Dickson DW, Wszolek ZK, Boeve BF, Ross OA, Lorenzo-Betancor O.

Neurobiol Aging. 2016 Sep;45:107-108. doi: 10.1016/j.neurobiolaging.2016.03.021. Epub 2016 Mar 24.

PMID:
27459931
42.

TREM2 p.R47H substitution is not associated with dementia with Lewy bodies.

Walton RL, Soto-Ortolaza AI, Murray ME, Lorenzo-Betancor O, Ogaki K, Heckman MG, Rayaprolu S, Rademakers R, Ertekin-Taner N, Uitti RJ, van Gerpen JA, Wszolek ZK, Smith GE, Kantarci K, Lowe VJ, Parisi JE, Jones DT, Savica R, Graff-Radford J, Knopman DS, Petersen RC, Graff-Radford NR, Ferman TJ, Dickson DW, Boeve BF, Ross OA, Labbé C.

Neurol Genet. 2016 Jul 14;2(4):e85. doi: 10.1212/NXG.0000000000000085. eCollection 2016 Aug.

43.

Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies.

Sarro L, Senjem ML, Lundt ES, Przybelski SA, Lesnick TG, Graff-Radford J, Boeve BF, Lowe VJ, Ferman TJ, Knopman DS, Comi G, Filippi M, Petersen RC, Jack CR Jr, Kantarci K.

Brain. 2016 Oct;139(Pt 10):2740-2750. Epub 2016 Jul 24.

44.

Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia.

Knopman DS, Jack CR Jr, Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Machulda MM, Roberts RO, Boeve BF, Jones DT, Petersen RC.

Neurology. 2016 Aug 16;87(7):691-8. doi: 10.1212/WNL.0000000000002979. Epub 2016 Jul 15.

45.

An autoradiographic evaluation of AV-1451 Tau PET in dementia.

Lowe VJ, Curran G, Fang P, Liesinger AM, Josephs KA, Parisi JE, Kantarci K, Boeve BF, Pandey MK, Bruinsma T, Knopman DS, Jones DT, Petrucelli L, Cook CN, Graff-Radford NR, Dickson DW, Petersen RC, Jack CR Jr, Murray ME.

Acta Neuropathol Commun. 2016 Jun 13;4(1):58. doi: 10.1186/s40478-016-0315-6.

46.

MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies.

Labbé C, Heckman MG, Lorenzo-Betancor O, Soto-Ortolaza AI, Walton RL, Murray ME, Allen M, Uitti RJ, Wszolek ZK, Smith GE, Kantarci K, Knopman DS, Lowe VJ, Jack CR Jr., Ertekin-Taner N, Hassan A, Savica R, Petersen RC, Parisi JE, Maraganore DM, Graff-Radford NR, Ferman TJ, Boeve BF, Dickson DW, Ross OA.

Alzheimers Dement. 2016 Dec;12(12):1297-1304. doi: 10.1016/j.jalz.2016.05.002. Epub 2016 Jun 7. Review.

47.

Predicting Survival in Dementia With Lewy Bodies With Hippocampal Volumetry.

Graff-Radford J, Lesnick TG, Boeve BF, Przybelski SA, Jones DT, Senjem ML, Gunter JL, Ferman TJ, Knopman DS, Murray ME, Dickson DW, Sarro L, Jack CR Jr, Petersen RC, Kantarci K.

Mov Disord. 2016 Jul;31(7):989-94. doi: 10.1002/mds.26666. Epub 2016 May 23.

48.

MR spectroscopy, APOE genotype, and evolving β-amyloid pathology: What is being detected and when.

Kantarci K, Goldberg TE.

Neurology. 2016 May 10;86(19):1750-1. doi: 10.1212/WNL.0000000000002680. Epub 2016 Apr 15. No abstract available.

PMID:
27164709
49.

Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition.

Kantarci K, Lowe VJ, Lesnick TG, Tosakulwong N, Bailey KR, Fields JA, Shuster LT, Zuk SM, Senjem ML, Mielke MM, Gleason C, Jack CR, Rocca WA, Miller VM.

J Alzheimers Dis. 2016 May 7;53(2):547-56. doi: 10.3233/JAD-160258.

50.

Plasma sphingolipid changes with autopsy-confirmed Lewy Body or Alzheimer's pathology.

Savica R, Murray ME, Persson XM, Kantarci K, Parisi JE, Dickson DW, Petersen RC, Ferman TJ, Boeve BF, Mielke MM.

Alzheimers Dement (Amst). 2016;3:43-50.

Supplemental Content

Loading ...
Support Center